Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.85% |
| 2 | Technology | 3.12% |
| 3 | Healthcare | 2.55% |
| 4 | Financials | 2.39% |
| 5 | Consumer Discretionary | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4701
B&G Foods
BGS
$206M
| $3.06M | ﹤0.01% |
185,546
-112,672
| -38% | -$2.5M |
2021 Q3
4 quarters
|
|
4702
PUT
AdvisorShares Pure US Cannabis ETF
MSOS
$849M
| $3.06M | ﹤0.01% |
343,300
-72,200
| -17% | -$833K |
2020 Q4
7 quarters
|
|
4703
PUT
Phillips Edison & Co
PECO
$4.81B
| $3.06M | ﹤0.01% |
108,900
+65,500
| +151% | +$2.15M |
2022 Q1
2 quarters
|
|
4704
Genesis Energy
GEL
$1.71B
| $3.05M | ﹤0.01% |
331,952
+48,500
| +17% | +$493K |
2021 Q3
4 quarters
|
|
4705
Columbus McKinnon
CMCO
$488M
| $3.05M | ﹤0.01% |
116,717
-16,871
| -13% | -$514K |
2020 Q3
8 quarters
|
|
4706
Children's Place
PLCE
$42.5M
| $3.05M | ﹤0.01% |
98,837
+46,866
| +90% | +$1.97M |
2018 Q2
17 quarters
|
|
4707
Vicor
VICR
$14.1B
| $3.05M | ﹤0.01% |
51,524
+2,154
| +4% | +$142K |
2021 Q4
3 quarters
|
|
|
FSSI
4708
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
| $3.05M | ﹤0.01% |
307,951
+1,962
| +0.6% | +$19.3K |
2021 Q1
6 quarters
|
|
4709
Kemper
KMPR
$1.52B
| $3.04M | ﹤0.01% |
73,799
-167,391
| -69% | -$7.83M |
2020 Q3
8 quarters
|
|
|
DHC
4710
Diversified Healthcare Trust
DHC
$1.83B
| $3.04M | ﹤0.01% |
3,073,478
+551,859
| +22% | +$885K |
2021 Q3
4 quarters
|
|
4711
iShares US Pharmaceuticals ETF
IHE
$1.6B
| $3.04M | ﹤0.01% |
+53,838
| New | +$3.32M |
2022 Q3
0 quarters
|
|
4712
PUT
Smith & Wesson
SWBI
$659M
| $3.04M | ﹤0.01% |
293,300
-202,900
| -41% | -$2.68M |
2013 Q2
37 quarters
|
|
4713
CALL
iShares US Financials ETF
IYF
$3.79B
| $3.04M | ﹤0.01% |
45,000
+41,200
| +1,084% | +$3.03M |
2022 Q2
1 quarter
|
|
4714
CALL
Guidewire Software
GWRE
$13.4B
| $3.04M | ﹤0.01% |
49,300
-25,800
| -34% | -$1.86M |
2016 Q4
23 quarters
|
|
4715
PUT
Jefferies Financial Group
JEF
$10.6B
| $3.04M | ﹤0.01% |
107,633
-23,535
| -18% | -$712K |
2021 Q1
6 quarters
|
|
4716
CALL
CBRE Group
CBRE
$37.5B
| $3.03M | ﹤0.01% |
44,900
-57,600
| -56% | -$4.57M |
2013 Q2
37 quarters
|
|
4717
PUT
Kyndryl
KD
$2.53B
| $3.03M | ﹤0.01% |
366,200
+121,480
| +50% | +$1.26M |
2021 Q4
3 quarters
|
|
4718
Standex International
SXI
$3.55B
| $3.03M | ﹤0.01% |
37,084
-6,388
| -15% | -$571K |
2017 Q1
22 quarters
|
|
4719
PUT
LGI Homes
LGIH
$1.08B
| $3.03M | ﹤0.01% |
37,200
-22,000
| -37% | -$2.15M |
2015 Q4
27 quarters
|
|
|
RXDX
4720
PUT
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $3.03M | ﹤0.01% |
51,300
+700
| +1% | +$32K |
2022 Q2
1 quarter
|
|
4721
CALL
Bruker
BRKR
$9.73B
| $3.02M | ﹤0.01% |
57,000
+34,600
| +154% | +$2.07M |
2021 Q1
6 quarters
|
|
|
ICPT
4722
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.02M | ﹤0.01% |
216,800
+129,900
| +149% | +$2.09M |
2014 Q1
34 quarters
|
|
|
EGLE
4723
PUT
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $3.02M | ﹤0.01% |
70,000
+40,600
| +138% | +$1.92M |
2021 Q4
3 quarters
|
|
4724
PUT
BioCryst Pharmaceuticals
BCRX
$2.07B
| $3.02M | ﹤0.01% |
239,800
-58,500
| -20% | -$753K |
2019 Q4
11 quarters
|
|
4725
Cullinan Oncology
CGEM
$1.03B
| $3.02M | ﹤0.01% |
235,603
-133,867
| -36% | -$1.8M |
2021 Q1
6 quarters
|
|
Similar funds
Citadel Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Citadel Advisors held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Citadel Advisors's Q3 2022 filing shows 1,622 new, 5,458 increased, 5,221 reduced and 1,857 closed positions. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M. The largest sale was Meta Platforms (Facebook), an estimated $349M.
By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 84% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Citadel Advisors added most to Apple in Q3 2022, an estimated $703M increase.
- Citadel Advisors's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Citadel Advisors fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Citadel Advisors's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Citadel Advisors opened 1,622 new positions and closed 1,857 in Q3 2022.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.